15.06.2021 13:00:00
|
TerrAscend Launches Kind Tree Branded Portfolio in Maryland
NEW YORK and TORONTO, June 15, 2021 /CNW/ - TerrAscend Corp. ("TerrAscend" or "the Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced it has launched a portfolio of its Kind Tree branded products in Maryland.
TerrAscend recently entered the Maryland market with the closing of the acquisition of HMS Health this past month. The Maryland facility is already cultivating over 15 strains of flower under the Kind Tree brand and is now launching manufactured form factors of Kind Tree vapes and half gram pre-rolls. Additional cultivation capacity, brands and formulations will come online in the second half of this year.
"The integration of HMS is progressing well, and the introduction of our Kind Tree brand is an important milestone in this process," said Jason Wild, Executive Chairman of TerrAscend. "Maryland is a key limited license market with strong growth potential, strategically located near our core Northeast markets of Pennsylvania and New Jersey. During the second half of 2021, we plan to significantly expand our cultivation and processing capacity in each of these underserved states."
Learn more at www.kindtreecannabis.com.
The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
About TerrAscend
TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania, New Jersey, and California, licensed cultivation and processing operations in Maryland and licensed production in Canada. TerrAscend operates an award-winning chain of The Apothecarium dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts. TerrAscend's best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market. The Company owns several synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com.
Forward Looking Information
This news release contains "forward-looking information" within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, "may", "would", "could", "will", "likely", "expect", "anticipate", "believe, "intend", "plan", "forecast", "project", "estimate", "outlook" and other similar expressions, and include statements with respect to future revenue and profits. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to, current and future market conditions; risks related to federal, state, provincial, territorial, local and foreign government laws, rules and regulations, including federal and state laws in the United States relating to cannabis operations in the United States; and the risk factors set out in the Company's most recently filed MD&A, filed with the Canadian securities regulators and available under the Company's profile on SEDAR at www.sedar.com.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Caution Regarding Cannabis Operations in the United States
Investors should note that there are significant legal restrictions and regulations that govern the cannabis industry in the United States. Cannabis remains a Schedule I drug under the US Controlled Substances Act, making it illegal under federal law in the United States to, among other things, cultivate, distribute, or possess cannabis in the United States. Financial transactions involving proceeds generated by, or intended to promote, cannabis-related business activities in the United States may form the basis for prosecution under applicable US federal money laundering legislation.
While the approach to enforcement of such laws by the federal government in the United States has trended toward non-enforcement against individuals and businesses that comply with medical or adult-use cannabis programs in states where such programs are legal, strict compliance with state laws with respect to cannabis will neither absolve TerrAscend of liability under US federal law, nor will it provide a defense to any federal proceeding which may be brought against TerrAscend. The enforcement of federal laws in the United States is a significant risk to the business of TerrAscend and any proceedings brought against TerrAscend thereunder may adversely affect TerrAscend's operations and financial performance.
SOURCE TerrAscend
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu TerrAscend Corp Registered Shsmehr Nachrichten
05.11.24 |
Ausblick: TerrAscend stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
22.10.24 |
Erste Schätzungen: TerrAscend stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
07.08.24 |
Ausblick: TerrAscend verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
24.07.24 |
Erste Schätzungen: TerrAscend gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) |
Analysen zu TerrAscend Corp Registered Shsmehr Analysen
Aktien in diesem Artikel
Teradyne Inc. | 121,26 | -0,02% | |
TerrAscend Corp Registered Shs | 0,62 | 3,33% |